Matches in SemOpenAlex for { <https://semopenalex.org/work/W2081138340> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W2081138340 endingPage "21" @default.
- W2081138340 startingPage "15" @default.
- W2081138340 abstract "The effects of intranasal and iv administration of His-D-Trp-Ala-Trp-D-Phe-Lys NH2 (GHRP) on plasma GH, PRL, LH, FSH, TSH, cortisol, insulin, IGF-I as well as GHRH-like immunoreactivity (LI) levels were examined in 6 healthy male subjects. An iv bolus injection of GHRP (lμg/kg BW) caused a remarkable increase in plasma GH levels with a mean (±SE) peak of 54.9±4.2μg/L. In addition an intranasal administration of GHRP resulted in a significant, dose-related increase in plasma GH with peaks of 39.6±15.3μg/L at a dose of 30μg/kg BW, 14.1±5.0μg/L at 15μEg/kg BW and 7.5±5.7μg/L at 5μg/kg BW. Plasma PRL and cortisol levels were slightly but significantly increased after iv administration of GHRP, whereas GHRP totally failed to affect plasma TSH, LH, FSH, insulin, blood sugar and GHRH-LI levels. Seven consecutive, intranasal administrations of 15μg/kg BW GHRP every 8h were well tolerated in all subjects examined. During this treatment, GH responsiveness to GHRP was not attenuated by desensitization and plasma IGF-I was increased from 94.5±5.8μg/L before GHRP to 125.8±6.0μg/L after repeated GHRP administration.These findings indicate that intranasal administration of GHRP stimulates GH secretion and consequently enhances IGF-I production in normal subjects. If GHRP is demonstrated to be beneficial in the treatment of some patients with GH deficiency, the intranasal route of administration may be more useful than the painful injections because a prolonged period is required for the treatment." @default.
- W2081138340 created "2016-06-24" @default.
- W2081138340 creator A5026634670 @default.
- W2081138340 creator A5033096899 @default.
- W2081138340 creator A5050107950 @default.
- W2081138340 creator A5052414377 @default.
- W2081138340 creator A5055338974 @default.
- W2081138340 creator A5056518129 @default.
- W2081138340 creator A5085842239 @default.
- W2081138340 creator A5089769676 @default.
- W2081138340 creator A5091861346 @default.
- W2081138340 date "1991-01-01" @default.
- W2081138340 modified "2023-09-23" @default.
- W2081138340 title "Intranasal Administration of His-D-Trp-Ala-Trp-D-Phe-LysNH2 (Growth Hormone Releasing Peptide) Increased Plasma Growth Hormone and Insulin-like Growth Factor-I Levels in Normal Men." @default.
- W2081138340 cites W1965658167 @default.
- W2081138340 cites W1968113184 @default.
- W2081138340 cites W1979641686 @default.
- W2081138340 cites W1988437373 @default.
- W2081138340 cites W2002404697 @default.
- W2081138340 cites W2007971998 @default.
- W2081138340 cites W2022761976 @default.
- W2081138340 cites W2034770449 @default.
- W2081138340 cites W2039052861 @default.
- W2081138340 cites W2045504088 @default.
- W2081138340 cites W2070004508 @default.
- W2081138340 cites W2077181804 @default.
- W2081138340 cites W2090419454 @default.
- W2081138340 doi "https://doi.org/10.1507/endocrj1954.38.15" @default.
- W2081138340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1915110" @default.
- W2081138340 hasPublicationYear "1991" @default.
- W2081138340 type Work @default.
- W2081138340 sameAs 2081138340 @default.
- W2081138340 citedByCount "49" @default.
- W2081138340 countsByYear W20811383402015 @default.
- W2081138340 countsByYear W20811383402018 @default.
- W2081138340 crossrefType "journal-article" @default.
- W2081138340 hasAuthorship W2081138340A5026634670 @default.
- W2081138340 hasAuthorship W2081138340A5033096899 @default.
- W2081138340 hasAuthorship W2081138340A5050107950 @default.
- W2081138340 hasAuthorship W2081138340A5052414377 @default.
- W2081138340 hasAuthorship W2081138340A5055338974 @default.
- W2081138340 hasAuthorship W2081138340A5056518129 @default.
- W2081138340 hasAuthorship W2081138340A5085842239 @default.
- W2081138340 hasAuthorship W2081138340A5089769676 @default.
- W2081138340 hasAuthorship W2081138340A5091861346 @default.
- W2081138340 hasBestOaLocation W20811383401 @default.
- W2081138340 hasConcept C126322002 @default.
- W2081138340 hasConcept C134018914 @default.
- W2081138340 hasConcept C185592680 @default.
- W2081138340 hasConcept C2779306644 @default.
- W2081138340 hasConcept C71315377 @default.
- W2081138340 hasConcept C71924100 @default.
- W2081138340 hasConcept C85663871 @default.
- W2081138340 hasConcept C98274493 @default.
- W2081138340 hasConceptScore W2081138340C126322002 @default.
- W2081138340 hasConceptScore W2081138340C134018914 @default.
- W2081138340 hasConceptScore W2081138340C185592680 @default.
- W2081138340 hasConceptScore W2081138340C2779306644 @default.
- W2081138340 hasConceptScore W2081138340C71315377 @default.
- W2081138340 hasConceptScore W2081138340C71924100 @default.
- W2081138340 hasConceptScore W2081138340C85663871 @default.
- W2081138340 hasConceptScore W2081138340C98274493 @default.
- W2081138340 hasIssue "1" @default.
- W2081138340 hasLocation W20811383401 @default.
- W2081138340 hasLocation W20811383402 @default.
- W2081138340 hasOpenAccess W2081138340 @default.
- W2081138340 hasPrimaryLocation W20811383401 @default.
- W2081138340 hasRelatedWork W1983641721 @default.
- W2081138340 hasRelatedWork W1995945960 @default.
- W2081138340 hasRelatedWork W2026226896 @default.
- W2081138340 hasRelatedWork W2041678535 @default.
- W2081138340 hasRelatedWork W2066345847 @default.
- W2081138340 hasRelatedWork W2089387278 @default.
- W2081138340 hasRelatedWork W2095179743 @default.
- W2081138340 hasRelatedWork W2130904138 @default.
- W2081138340 hasRelatedWork W2748952813 @default.
- W2081138340 hasRelatedWork W4230655895 @default.
- W2081138340 hasVolume "38" @default.
- W2081138340 isParatext "false" @default.
- W2081138340 isRetracted "false" @default.
- W2081138340 magId "2081138340" @default.
- W2081138340 workType "article" @default.